InvestorsHub Logo
Followers 8
Posts 1894
Boards Moderated 0
Alias Born 05/05/2016

Re: Whalatane post# 15465

Thursday, 06/30/2022 10:40:29 AM

Thursday, June 30, 2022 10:40:29 AM

Post# of 17532
[quote]So if U were a BP Ceo …. Would U buy AUPH knowing that at least the data KZR has on the refractory patients was pretty impressive [/quote]Yes, I would buy it. That would give the acquiring company years of time to fully penetrate the market, and the fear of a competitor coming online (maybe!) with marginal advantages (maybe!), very little reason to worry.

It seems that to get the medical community to accept a new drug is like turning an ocean liner quickly. It's not easy. A multi-year head-start would be very hard to overcome, unless KZR demonstrates a huge advantage in efficacy and convenience and side effects, which the trial just published does not indicate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News